Infusion-related reactions with administration of avelumab: Mild and manageable side effects

James L. Gulley, Karen Kelly

Research output: Contribution to journalLetter

1 Citation (Scopus)
Original languageEnglish (US)
Pages (from-to)S1296-S1298
JournalTranslational Cancer Research
Volume6
DOIs
StatePublished - Oct 1 2017

ASJC Scopus subject areas

  • Oncology
  • Radiology Nuclear Medicine and imaging
  • Cancer Research

Cite this

Infusion-related reactions with administration of avelumab : Mild and manageable side effects. / Gulley, James L.; Kelly, Karen.

In: Translational Cancer Research, Vol. 6, 01.10.2017, p. S1296-S1298.

Research output: Contribution to journalLetter

@article{66cc94f384a14560a6eedb39010fb72d,
title = "Infusion-related reactions with administration of avelumab: Mild and manageable side effects",
author = "Gulley, {James L.} and Karen Kelly",
year = "2017",
month = "10",
day = "1",
doi = "10.21037/tcr.2017.09.44",
language = "English (US)",
volume = "6",
pages = "S1296--S1298",
journal = "Translational Cancer Research",
issn = "2218-676X",
publisher = "AME Publishing Company",

}

TY - JOUR

T1 - Infusion-related reactions with administration of avelumab

T2 - Mild and manageable side effects

AU - Gulley, James L.

AU - Kelly, Karen

PY - 2017/10/1

Y1 - 2017/10/1

UR - http://www.scopus.com/inward/record.url?scp=85031999112&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85031999112&partnerID=8YFLogxK

U2 - 10.21037/tcr.2017.09.44

DO - 10.21037/tcr.2017.09.44

M3 - Letter

AN - SCOPUS:85031999112

VL - 6

SP - S1296-S1298

JO - Translational Cancer Research

JF - Translational Cancer Research

SN - 2218-676X

ER -